Clinical Trials
3 trialsNCT03897036 2025-05-20
Treatment Duration Increment and Pharmacodynamic Study of CX-4945 in Patients With Basal Cell Carcinoma (BCC)
Senhwa Biosciences, Inc.
Phase 1 Completed
NCT02128282 2021-10-22
Study of CX-4945 in Combination With Gemcitabine and Cisplatin for Frontline Treatment of Cholangiocarcinoma
Senhwa Biosciences, Inc.
Phase 1/2 Completed
NCT01199718 2011-06-15
Study of CX-4945 in Patients With Relapsed or Refractory Multiple Myeloma
Cylene Pharmaceuticals
Phase 1 Unknown